Agile Therapeutics (AGRX) Fair Value Target Raised to $9 at Janney
Tweet Send to a Friend
Janney analyst Esther Hong raised the fair value target on Agile Therapeutics (NASDAQ: AGRX) to $9.00 (from $4.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
